391 related articles for article (PubMed ID: 6587396)
1. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids.
Steinbrecher UP; Parthasarathy S; Leake DS; Witztum JL; Steinberg D
Proc Natl Acad Sci U S A; 1984 Jun; 81(12):3883-7. PubMed ID: 6587396
[TBL] [Abstract][Full Text] [Related]
2. Role of endothelial cells and their products in the modification of low-density lipoproteins.
van Hinsbergh VW; Scheffer M; Havekes L; Kempen HJ
Biochim Biophys Acta; 1986 Aug; 878(1):49-64. PubMed ID: 3730414
[TBL] [Abstract][Full Text] [Related]
3. Lipid peroxidation of low density lipoprotein by human endothelial cells modifies its metabolism in vitro.
Masana L; Shaikh M; La Ville A; Lewis B
Rev Esp Fisiol; 1986 Mar; 42(1):99-104. PubMed ID: 3715160
[TBL] [Abstract][Full Text] [Related]
4. Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein.
Parthasarathy S; Steinbrecher UP; Barnett J; Witztum JL; Steinberg D
Proc Natl Acad Sci U S A; 1985 May; 82(9):3000-4. PubMed ID: 3857630
[TBL] [Abstract][Full Text] [Related]
5. Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism.
Steinbrecher UP; Witztum JL; Parthasarathy S; Steinberg D
Arteriosclerosis; 1987; 7(2):135-43. PubMed ID: 3107534
[TBL] [Abstract][Full Text] [Related]
6. Probucol inhibits oxidative modification of low density lipoprotein.
Parthasarathy S; Young SG; Witztum JL; Pittman RC; Steinberg D
J Clin Invest; 1986 Feb; 77(2):641-4. PubMed ID: 3944273
[TBL] [Abstract][Full Text] [Related]
7. Enzymatic modification of low density lipoprotein by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification.
Sparrow CP; Parthasarathy S; Steinberg D
J Lipid Res; 1988 Jun; 29(6):745-53. PubMed ID: 3139813
[TBL] [Abstract][Full Text] [Related]
8. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins.
Henriksen T; Mahoney EM; Steinberg D
Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6499-503. PubMed ID: 6273873
[TBL] [Abstract][Full Text] [Related]
9. Endothelial cells prevent accumulation of lipid hydroperoxides in low-density lipoprotein.
Smalley DM; Hogg N; Kalyanaraman B; Pritchard KA
Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3469-74. PubMed ID: 9437194
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms involved in the in vitro modification of low density lipoprotein by human umbilical vein endothelial cells and copper ions.
Cominacini L; Garbin U; De Santis A; Campagnola M; Davoli A; Pasini AF; Faccini G; Pasqualini E; Bertozzo L; Micciolo R; Pastorino AM; Lo Cascio V
J Lipid Mediat Cell Signal; 1996 Jan; 13(1):19-33. PubMed ID: 8821808
[TBL] [Abstract][Full Text] [Related]
11. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein.
Parthasarathy S; Barnett J; Fong LG
Biochim Biophys Acta; 1990 May; 1044(2):275-83. PubMed ID: 2344447
[TBL] [Abstract][Full Text] [Related]
12. Panax quinquefolium saponins protects low density lipoproteins from oxidation.
Li J; Huang M; Teoh H; Man RY
Life Sci; 1999; 64(1):53-62. PubMed ID: 10027742
[TBL] [Abstract][Full Text] [Related]
13. Enhanced macrophage degradation of biologically modified low density lipoprotein.
Henriksen T; Mahoney EM; Steinberg D
Arteriosclerosis; 1983; 3(2):149-59. PubMed ID: 6838433
[TBL] [Abstract][Full Text] [Related]
14. Novel phospholipolytic activities associated with electronegative low-density lipoprotein are involved in increased self-aggregation.
Bancells C; Benítez S; Villegas S; Jorba O; Ordóñez-Llanos J; Sánchez-Quesada JL
Biochemistry; 2008 Aug; 47(31):8186-94. PubMed ID: 18605697
[TBL] [Abstract][Full Text] [Related]
15. Recognition of solubilized apoproteins from delipidated, oxidized low density lipoprotein (LDL) by the acetyl-LDL receptor.
Parthasarathy S; Fong LG; Otero D; Steinberg D
Proc Natl Acad Sci U S A; 1987 Jan; 84(2):537-40. PubMed ID: 3467373
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidylcholine: essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein.
Yokoyama M; Hirata K; Miyake R; Akita H; Ishikawa Y; Fukuzaki H
Biochem Biophys Res Commun; 1990 Apr; 168(1):301-8. PubMed ID: 2328007
[TBL] [Abstract][Full Text] [Related]
17. Alteration of lysophosphatidylcholine content in low density lipoprotein after oxidative modification: relationship to endothelium dependent relaxation.
Liu SY; Lu X; Choy S; Dembinski TC; Hatch GM; Mymin D; Shen X; Angel A; Choy PC; Man RY
Cardiovasc Res; 1994 Oct; 28(10):1476-81. PubMed ID: 8001034
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein-mediated inhibition of endothelial cell production of platelet-derived growth factor-like protein depends on free radical lipid peroxidation.
Fox PL; Chisolm GM; DiCorleto PE
J Biol Chem; 1987 May; 262(13):6046-54. PubMed ID: 3571245
[TBL] [Abstract][Full Text] [Related]
19. Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells.
Khan BV; Parthasarathy SS; Alexander RW; Medford RM
J Clin Invest; 1995 Mar; 95(3):1262-70. PubMed ID: 7533787
[TBL] [Abstract][Full Text] [Related]
20. A critical overview of the chemistry of copper-dependent low density lipoprotein oxidation: roles of lipid hydroperoxides, alpha-tocopherol, thiols, and ceruloplasmin.
Burkitt MJ
Arch Biochem Biophys; 2001 Oct; 394(1):117-35. PubMed ID: 11566034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
